Skandinaviska Enskilda Banken AB publ Trims Position in Cardinal Health, Inc. $CAH

Skandinaviska Enskilda Banken AB publ reduced its holdings in Cardinal Health, Inc. (NYSE:CAH) by 23.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 80,288 shares of the company’s stock after selling 25,248 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Cardinal Health were worth $13,488,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Greykasell Wealth Strategies Inc. purchased a new position in shares of Cardinal Health during the first quarter worth $26,000. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Atlantic Edge Private Wealth Management LLC grew its position in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. Vermillion & White Wealth Management Group LLC raised its stake in shares of Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 71 shares during the last quarter. Finally, NewSquare Capital LLC lifted its holdings in shares of Cardinal Health by 100.0% in the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after buying an additional 107 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $212.26 on Friday. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $214.93. The firm has a market capitalization of $50.43 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. The business’s 50 day moving average price is $177.57 and its 200-day moving average price is $163.40.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping the consensus estimate of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue was up 22.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio is 30.77%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CAH shares. UBS Group upped their target price on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research note on Friday, October 31st. Evercore ISI boosted their price target on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Finally, Jefferies Financial Group set a $220.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.